Ultrasonic Neuromodulation for Treatment of Cognitive Impairment
NCT ID: NCT06135051
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE1/PHASE2
1 participants
INTERVENTIONAL
2024-08-18
2024-08-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of NeuroAD on Alzheimer Patients
NCT01825317
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT05417555
Transcranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment Alzheimer's Disease
NCT05251649
Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance
NCT03112902
Transcranial Pulse Stimulation of the Brain
NCT05910619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active stimulation
Low-intensity transcranial focused ultrasound stimulation of deep brain targets affected by Alzheimer's disease.
Diadem prototype
The device delivers low-intensity ultrasonic waves into specific brain targets.
Sham stimulation
Sham stimulation that applies the device in the same way as verum but only delivers auditory sounds correspoding to the ultrasonic pulses.
Diadem prototype
The device delivers low-intensity ultrasonic waves into specific brain targets.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diadem prototype
The device delivers low-intensity ultrasonic waves into specific brain targets.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 65-80
* MOCA \> 18
Exclusion Criteria
* Clinical symptoms or findings suggestive of alternative diagnosis or co-pathology
* Inability to complete MRI
* Suicidal ideation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Kubanek
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB_00173042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.